FindTrial
Sign In

The effective of clinical research of integrated Chinese traditional and western medicine protocol on women with diminished ovarian function

Wenshenyangxue granule on diminished ovary reserve women in IVF: A single center, Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16010090
Enrollment
Unknown
Registered
2016-12-05
Start date
2016-11-14
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diminished ovary function

Interventions

treatment group:supplement of Wenshen Yangxue Granule
control group:placebo treatment

Sponsors

Beijing Obstetric & Gynecology Hospital, Capital Medical Univercity
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Female who meet the diagnostic criteria of diminished ovary function. Married female whose age is between 20 to 40. Infertile female who need IVF-ET or have recived IVF-ET less than three cycles. Subjects were informed, voluntary signing informed consent.

Exclusion criteria

Exclusion criteria: Infertility caused by uterine malformations.Infertility patients with polycystic ovary syndrome, abnormal thyroid function and other complications.Patients with other serious organs diseases.Infertility caused by male factors. Infertility patients who have recived IVF-ET more than 2 cycles.

Design outcomes

Primary

MeasureTime frame
oocyte retrieved;—

Secondary

MeasureTime frame
antral follicle count;Anti-Mullerian Hormone, AMH;follicle stimulation hormone;endometrial thickness;good quality embryo rate;fertilization rate;pregnant rate;—

Countries

China

Contacts

Public ContactMa Yanmin

Beijing Obstetric & Gynecology Hospital, Capital Medical Univercity

minyanma@163.com+86 13521721961

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026